Large Language Models May Aid Emergency Department Triage
By Lori Solomon HealthDay Reporter
TUESDAY, May 14, 2024 -- Large language models (LLMs) could enhance emergency department triage workflows, according to a study published online May 7 in JAMA Network Open.
Christopher Y.K. Williams, M.B., B.Chir., from the Bakar Computational Health Sciences Institute at the University of California, San Francisco, and colleagues examined whether an LLM accurately assessed clinical acuity in the emergency department. The analysis included 10,000 pairs of emergency department visits (Jan. 1, 2012, to Jan. 17, 2023) with nonequivalent Emergency Severity Index (ESI) scores balanced for each of the 10 possible pairs of five ESI scores. The LLM examined acuity based on presenting histories extracted from physician notes.
The researchers found that the LLM correctly inferred the patient with higher acuity for 8,940 of 10,000 pairs (accuracy, 0.89). A previous comparator LLM had a lower performance (accuracy, 0.84). For the manually classified 500-pair subsample, LLM performance (accuracy, 0.88) was similar to that of the physician reviewer (accuracy, 0.86).
"Our findings suggest that an LLM could perform the complex task of evaluating clinical acuity," the authors write. "The integration of LLMs into emergency department workflows could enhance triage processes while maintaining triage quality and warrants further investigation."
Several authors disclosed ties to the technology or pharmaceutical industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.